Oldest pages

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Physical activity in sudden unexpected death in epilepsy: Much more than a simple sport‏‎ (10:15, 15 July 2017)
  2. Hypoxaemia and cardiorespiratory changes during epileptic seizures in young children‏‎ (14:04, 25 July 2017)
  3. Physiological time-series analysis: what does regularity quantify?‏‎ (09:34, 17 October 2017)
  4. Hippocampal input to a “visceral motor” corticobulbar pathway: An anatomical and electrophysiological study in the rat‏‎ (06:39, 17 August 2018)
  5. All pages‏‎ (23:15, 25 August 2018)
  6. 18-year old patient with anti-epileptic therapy and sudden cardiac death‏‎ (13:01, 17 June 2019)
  7. 294 medicolegal autopsies on epileptics: Cerebral findings‏‎ (13:01, 17 June 2019)
  8. A case of neurogenic pulmonary edema associated with epileptic seizure‏‎ (13:01, 17 June 2019)
  9. A case of seizure-related bradycardia and asystole‏‎ (13:01, 17 June 2019)
  10. A correlation of autonomic and EEG components in temporal lobe epilepsy‏‎ (13:01, 17 June 2019)
  11. Activation of limbic structures during CO2-stimulated breathing in awake man‏‎ (13:01, 17 June 2019)
  12. Adult hippocampal neurogenesis and sudden unexpected death in epilepsy: Reality or just an attractive history?‏‎ (13:02, 17 June 2019)
  13. After sudden unexpected death in epilepsy: Lessons learned and the road forward‏‎ (13:02, 17 June 2019)
  14. Alteration of cardiac function in patients with temporal lobe epilepsy: Different roles of EEG-ECG monitoring and spectral analysis of RR variability‏‎ (13:02, 17 June 2019)
  15. Amygdala and hippocampus are symptomatogenic zones for central apneic seizures‏‎ (13:02, 17 June 2019)
  16. Amygdala sclerosis in sudden and unexpected death in epilepsy‏‎ (13:02, 17 June 2019)
  17. A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal cortices‏‎ (13:07, 17 June 2019)
  18. Adenosine: a potential mediator of seizure arrest and post-ictal refractoriness‏‎ (13:07, 17 June 2019)
  19. Amygdala-stimulation-induced apnea is attention and nasal breathing dependent‏‎ (13:08, 17 June 2019)
  20. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat‏‎ (13:08, 17 June 2019)
  21. An animal model for SUDEP: The questions shape the answers‏‎ (13:08, 17 June 2019)
  22. A nationwide survey of the extent of autopsy in sudden unexplained death in epilepsy‏‎ (13:08, 17 June 2019)
  23. An electroclinical case-control study of sudden unexpected death in epilepsy‏‎ (13:08, 17 June 2019)
  24. An observation of the effect of the electrical stimulation of the temporal lobes on blood pressure in man‏‎ (13:08, 17 June 2019)
  25. A novel mouse model for sudden unexpected death in epilepsy (SUDEP): Role of impaired adenosine clearance‏‎ (13:09, 17 June 2019)
  26. Anoxia-ischemia: A mechanism of seizure termination in ictal asystole‏‎ (13:09, 17 June 2019)
  27. Anoxic-epileptic seizures: observational study of epileptic seizures induced by syncopes‏‎ (13:09, 17 June 2019)
  28. Anticonvulsant drug effects on spontaneous thalamocortical rhythms in vitro: Phenytoin, carbamazepine, and phenobarbital‏‎ (13:09, 17 June 2019)
  29. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: A case-control study‏‎ (13:09, 17 June 2019)
  30. Apnoea and bradycardia during epileptic seizures: Relation to sudden death in epilepsy‏‎ (13:09, 17 June 2019)
  31. A population-based post mortem study of sudden unexpected death in epilepsy‏‎ (13:09, 17 June 2019)
  32. A prospective study on sudden unexpected death in epilepsy‏‎ (13:09, 17 June 2019)
  33. Are geomagnetic disturbances a risk factor for the sudden unexplained death of epileptic children?‏‎ (13:09, 17 June 2019)
  34. A reprassial of mortality after epilepsy surgery‏‎ (13:10, 17 June 2019)
  35. A review of sudden unexpected death in epilepsy: Prediction of patients at risk‏‎ (13:10, 17 June 2019)
  36. Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death‏‎ (13:10, 17 June 2019)
  37. Ascending projection from the respiratory centre to mesencephalon and diencephalon‏‎ (13:10, 17 June 2019)
  38. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy‏‎ (13:10, 17 June 2019)
  39. Association of prone position with sudden unexpected death in epilepsy‏‎ (13:10, 17 June 2019)
  40. Asystole induced by electrical stimulation of the left cingulate gyrus‏‎ (13:10, 17 June 2019)
  41. Asystole induced by partial seizures: A rare cause of syncope‏‎ (13:10, 17 June 2019)
  42. Asystolic Seizures‏‎ (13:11, 17 June 2019)
  43. Automated non-EEG based seizure detection: Do users have a say?‏‎ (13:11, 17 June 2019)
  44. Autonomic changes following generalized tonic clonic seizures: An analysis of adult and pediatric patients with epilepsy‏‎ (13:11, 17 June 2019)
  45. Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity‏‎ (13:11, 17 June 2019)
  46. Autonomic effects on stimulating rostral portion of cingulate gyri in man‏‎ (13:11, 17 June 2019)
  47. Autonomic epilepsy‏‎ (13:11, 17 June 2019)
  48. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial‏‎ (13:11, 17 June 2019)
  49. Benefits of sunlight: Vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy‏‎ (13:11, 17 June 2019)
  50. Bradyarrhythmias induced by antiepileptics increase frequency of epileptic seizures‏‎ (13:12, 17 June 2019)
  51. Bradycardia and asystole induced by partial seizures: A case report and literature review‏‎ (13:12, 17 June 2019)
  52. Bradycardia and syncope as manifestations of partial epilepsy‏‎ (13:12, 17 June 2019)
  53. Bradycardia and tachycardia following electrical stimulation of the amygdaloid region in monkey‏‎ (13:12, 17 June 2019)
  54. Bradycardia, an epileptic ictal manifestation‏‎ (13:12, 17 June 2019)
  55. Brain seizes, heart ceases: a case of ictal asystole‏‎ (13:12, 17 June 2019)
  56. Breathing inhibited when seizures spread to the amygdala and upon amygdala stimulation‏‎ (13:12, 17 June 2019)
  57. Breathing: rhythmicity, plasticity, chemosensitivity‏‎ (13:12, 17 June 2019)
  58. Can SCN1A mutations account for SUDEP?‏‎ (13:13, 17 June 2019)
  59. Can sudden unexplained death in epilepsy be prevented?‏‎ (13:13, 17 June 2019)
  60. Can technology help reduce risk of harm in patients with epilepsy?‏‎ (13:13, 17 June 2019)
  61. Capillary leak syndrome with pulmonary edema‏‎ (13:13, 17 June 2019)
  62. Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy‏‎ (13:13, 17 June 2019)
  63. Carbamazepine and cardiac conduction disturbances‏‎ (13:13, 17 June 2019)
  64. Carbamazepine induced bradycardia – A problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study‏‎ (13:13, 17 June 2019)
  65. Cardiac activity during epileptic seizures‏‎ (13:13, 17 June 2019)
  66. Cardiac and respiratory correlations with unit discharge in epileptic human temporal lobe‏‎ (13:13, 17 June 2019)
  67. Cardiac and respiratory correlations with unit discharge in human amygdala and hippocampus‏‎ (13:14, 17 June 2019)
  68. Cardiac and respiratory relationships with neural discharge in the anterior cingulate cortex during sleep-walking states‏‎ (13:14, 17 June 2019)
  69. Cardiac arrest due to partial epileptic seizures‏‎ (13:14, 17 June 2019)
  70. Cardiac arrhythmias and SUDEP--Commentary on Hindocha et al.‏‎ (13:14, 17 June 2019)
  71. Cardiac arrhythmias during or after epileptic seizures‏‎ (13:14, 17 June 2019)
  72. Cardiac arrhythmias in focal epilepsy: A prospective long-term study‏‎ (13:14, 17 June 2019)
  73. Cardiac arrhythmias in the differential diagnosis of epilepsy‏‎ (13:14, 17 June 2019)
  74. Cardiac arrhythmias of genetic origin are important contributors to sudden infant death syndrome‏‎ (13:14, 17 June 2019)
  75. Cardiac asystole and bradycardia as a manifestation of left temporal lobe complex partial seizure‏‎ (13:15, 17 June 2019)
  76. Cardiac asystole associated with epileptic seizures: A case report with simultaneous EEG and ECG‏‎ (13:15, 17 June 2019)
  77. Cardiac asystole in epilepsy: Clinical and neurophysiologic features‏‎ (13:15, 17 June 2019)
  78. Cardiac asystole in partial seizures‏‎ (13:15, 17 June 2019)
  79. Cardiac asystole masquerading as temporal lobe epilepsy‏‎ (13:15, 17 June 2019)
  80. Cardiac causes of sudden death: Virtual panel discussion of posed questions‏‎ (13:15, 17 June 2019)
  81. Cardiac causes of sudden unexpected death in children and their relationship to seizures and syncope: Genetic testing for cardiac electropathies‏‎ (13:15, 17 June 2019)
  82. Cardiac dysrhythmia associated with the immediate postictal state after maximal electroshock in freely moving rat‏‎ (13:15, 17 June 2019)
  83. Cardiac effects of seizures‏‎ (13:16, 17 June 2019)
  84. Cardiac manifestations of complex partial seizures‏‎ (13:16, 17 June 2019)
  85. Cardiac neural discharge and epileptogenic activity in the cat: An animal model for unexplained death‏‎ (13:16, 17 June 2019)
  86. Cardiac rhythm during temporal lobe seizures‏‎ (13:16, 17 June 2019)
  87. Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?‏‎ (13:16, 17 June 2019)
  88. Cardiogenic seizure with bradyarrhythmia: documentation of the mechanism during asystole‏‎ (13:16, 17 June 2019)
  89. Cardiogenic syncope in temporal lobe epileptic seizures‏‎ (13:16, 17 June 2019)
  90. Cardiopulmonary surveillance to prevent SUDEP‏‎ (13:16, 17 June 2019)
  91. Cardiopulmonary surveillance to prevent SUDEP – Authors’ reply‏‎ (13:16, 17 June 2019)
  92. Cardiorespiratory control during sleep‏‎ (13:17, 17 June 2019)
  93. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP)‏‎ (13:17, 17 June 2019)
  94. Cardiovascular and respiratory relationships with neuronal discharge in the central nucleus of the amygdala during sleep-waking states‏‎ (13:17, 17 June 2019)
  95. Cardiovascular and respiratory responses to electrical and chemical stimulation of the hippocampus in anesthetized and awake rats‏‎ (13:17, 17 June 2019)
  96. Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies‏‎ (13:17, 17 June 2019)
  97. Cardiovascular causes of loss of consciousness in patients with presumed epilepsy: a cause of the increased sudden death rate in people with epilepsy?‏‎ (13:17, 17 June 2019)
  98. Cardiovascular effects of human insular cortex stimulation‏‎ (13:17, 17 June 2019)
  99. Case-control study of associated conditions at the time of death in patients with epilepsy‏‎ (13:17, 17 June 2019)
  100. Case-control study of SUDEP‏‎ (13:18, 17 June 2019)
  101. Cause of death and predictors of mortality in a community-based cohort of people with epilepsy‏‎ (13:18, 17 June 2019)
  102. Causes of death in epilepsy patients who died in a Cuban psychiatric hospital‏‎ (13:18, 17 June 2019)
  103. Causes of death in institutionalized epileptics‏‎ (13:18, 17 June 2019)
  104. Causes of sudden unexpected deaths in young and middle-aged persons‏‎ (13:18, 17 June 2019)
  105. Cause-specific mortality in epilepsy: A cohort study of more than 9,000 patients once hospitalized for epilepsy‏‎ (13:18, 17 June 2019)
  106. Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death‏‎ (13:18, 17 June 2019)
  107. Central cardio-autonomic disorganization in interictal states of epilepsy detected by phase space analysis‏‎ (13:18, 17 June 2019)
  108. Cerebral arrhythmia influencing cardiac rhythm: A case of ictal bradycardia‏‎ (13:19, 17 June 2019)
  109. Cerebral autoregulation improves in epilepsy patients after temporal lobe surgery‏‎ (13:19, 17 June 2019)
  110. Cerebral correlates of autonomic cardiovascular arousal: A functional neuroimaging investigation in humans‏‎ (13:19, 17 June 2019)
  111. Cerebral hemispheric lateralization in cardiac autonomic control‏‎ (13:19, 17 June 2019)
  112. Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans‏‎ (13:19, 17 June 2019)
  113. Certification of deaths attributable to epilepsy‏‎ (13:19, 17 June 2019)
  114. Cessation of the pulse during the onset of epileptic fits‏‎ (13:19, 17 June 2019)
  115. Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death‏‎ (13:19, 17 June 2019)
  116. Changes in plasma catecholamines after tonic-clonic seizures‏‎ (13:20, 17 June 2019)
  117. Changes in respiratory-modulated neural activities, consistent with obstructive and central apnea, during fictive seizures in an in situ anaesthetized rat preparation‏‎ (13:20, 17 June 2019)
  118. Circadian variation in heart-rate variability in localization-related epilepsy‏‎ (13:20, 17 June 2019)
  119. Circulatory and respiratory changes induced by electrical stimulation of limbic system (visceral brain)‏‎ (13:20, 17 June 2019)
  120. Circulatory effects of cortical stimulation‏‎ (13:20, 17 June 2019)
  121. Circumstances of death in sudden death in epilepsy: interviews of bereaved relatives‏‎ (13:20, 17 June 2019)
  122. Clinical features of sudden unexpected death in epilepsy‏‎ (13:20, 17 June 2019)
  123. Clinical pharmacology: drugs as a benefit and/or risk in sudden unexpected death in epilepsy?‏‎ (13:20, 17 June 2019)
  124. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies‏‎ (13:21, 17 June 2019)
  125. CNS innervation of posterior cricoarytenoid muscles: A transneuronal labeling study‏‎ (13:21, 17 June 2019)
  126. CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus‏‎ (13:21, 17 June 2019)
  127. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada‏‎ (13:21, 17 June 2019)
  128. Combined analysis of risk factors for SUDEP‏‎ (13:21, 17 June 2019)
  129. Community-based study of mortality in children with epilepsy‏‎ (13:21, 17 June 2019)
  130. Comparison of anti-epileptic drug levels in different cases of sudden death‏‎ (13:21, 17 June 2019)
  131. Comparison of antiepileptic drug levels in sudden unexpected deaths in epilepsy with deaths from other causes‏‎ (13:21, 17 June 2019)
  132. Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: II. Reciprocal and non-reciprocal connections‏‎ (13:22, 17 June 2019)
  133. Complete atrio-ventricular conduction block during complex partial seizure‏‎ (13:22, 17 June 2019)
  134. Computerized seizure detection based on heart rate changes‏‎ (13:22, 17 June 2019)
  135. Coroner and medical examiner documentation of sudden unexplained deaths in epilepsy‏‎ (13:22, 17 June 2019)
  136. Coroners’ autopsy reporting of sudden unexplained death in epilepsy (SUDEP) in the UK‏‎ (13:22, 17 June 2019)
  137. Could sudden cardiac death in epilepsy be related to the occurrence of thalamic dysfunction or anatomic change?‏‎ (13:22, 17 June 2019)
  138. Could sudden death syndrome (SDS) in chickens (Gallus gallus) be a valid animal model for sudden unexpected death in epilepsy (SUDEP)?‏‎ (13:22, 17 June 2019)
  139. Death in children with epilepsy: A population-based study‏‎ (13:22, 17 June 2019)
  140. Death in the shadows‏‎ (13:22, 17 June 2019)
  141. Death in Unverricht-Lundborg disease‏‎ (13:23, 17 June 2019)
  142. Deaths from epilepsy: What next?‏‎ (13:23, 17 June 2019)
  143. Decreased neuronal burst discharge near site of seizure onset in epileptic human temporal lobes‏‎ (13:23, 17 June 2019)
  144. Decrease of sympathetic cardiovascular modulation after temporal lobe epilepsy surgery‏‎ (13:23, 17 June 2019)
  145. Demystifying sudden unexplained death in epilepsy – Are we close?‏‎ (13:23, 17 June 2019)
  146. Detecting nocturnal convulsions: Efficacy of the MP5 monitor‏‎ (13:23, 17 June 2019)
  147. Development of cardiac innervation, ventricular fibrillation, and sudden infant death syndrome‏‎ (13:23, 17 June 2019)
  148. Diagnostic accuracy of audio-based seizure detection in patients with severe epilepsy and an intellectual disability‏‎ (13:23, 17 June 2019)
  149. Differential effects of right unilateral and bilateral ECT on heart rate‏‎ (13:24, 17 June 2019)
  150. Direct hypothalamo-autonomic connections‏‎ (13:24, 17 June 2019)
  151. Direct projections from the ventrolateral medulla oblongata to the limbic forebrain: Anterograde and retrograde tract-tracing studies in the rat‏‎ (13:24, 17 June 2019)
  152. Do alterations in inter-ictal heart rate variability predict sudden unexpected death in epilepsy?‏‎ (13:24, 17 June 2019)
  153. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?‏‎ (13:24, 17 June 2019)
  154. Does cardiac conduction pathology contribute to sudden unexpected death in epilepsy?‏‎ (13:24, 17 June 2019)
  155. Does epilepsy surgery really lower mortality?‏‎ (13:24, 17 June 2019)
  156. Does lateralized hemispheric control of cardiovascular activity exist? A Wada test study‏‎ (13:24, 17 June 2019)
  157. Does the lunar phase have an effect on sudden unexpected death in epilepsy?‏‎ (13:25, 17 June 2019)
  158. Dynamics of convulsive seizure termination and postictal generalized EEG suppression‏‎ (13:25, 17 June 2019)
  159. ECG abnormalities in epileptics‏‎ (13:25, 17 June 2019)
  160. ECG abnormalities in patients with epilepsy‏‎ (13:25, 17 June 2019)
  161. Echo-planar functional MR imaging of epilepsy with concurrent EEG monitoring‏‎ (13:25, 17 June 2019)
  162. EEG and ECG in sudden unexplained death in epilepsy‏‎ (13:25, 17 June 2019)
  163. Effect of phenobarbital pretreatment on cardiac neural discharge and pentylenetetrazol-induced epileptogenic activity in the cat‏‎ (13:25, 17 June 2019)
  164. Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man‏‎ (13:25, 17 June 2019)
  165. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans‏‎ (13:25, 17 June 2019)
  166. Effects of phenobarbital on cerebral blood flow during hypoxia‏‎ (13:26, 17 June 2019)
  167. Effects of seizure repetition on postictal and interictal neurocardiac regulation in the rat‏‎ (13:26, 17 June 2019)
  168. Effects of seizure severity and seizure repetition on postictal cardiac arrhythmia following maximal electroshock‏‎ (13:26, 17 June 2019)
  169. Effects of Seizures on Autonomic and Cardiovascular Function‏‎ (13:26, 17 June 2019)
  170. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents‏‎ (13:26, 17 June 2019)
  171. Effects of vagus nerve stimulation on cardiovascular regulation in patients with epilepsy‏‎ (13:26, 17 June 2019)
  172. Effect upon blood pressure of electrical stimulation of tips of temporal lobes in man‏‎ (13:26, 17 June 2019)
  173. EKG abnormalities during partial seizures in refractory epilepsy‏‎ (13:26, 17 June 2019)
  174. EKG abnormalities in children and adolescents with symptomatic temporal lobe epilepsy‏‎ (13:27, 17 June 2019)
  175. Electrocardiographic accompaniments of temporal lobe epileptic seizures‏‎ (13:27, 17 June 2019)
  176. Electrocardiographic changes at the onset of epileptic seizures‏‎ (13:27, 17 June 2019)
  177. Electrocardiographic changes during electrographic seizures‏‎ (13:27, 17 June 2019)
  178. Electrocardiographic disorders associated to recent onset epilepsy‏‎ (13:27, 17 June 2019)
  179. Electrocardiograph QT lengthening associated with epileptiform EEG discharges – A role in sudden unexplained death in epilepsy?‏‎ (13:27, 17 June 2019)
  180. Electrocardiography in epilepsy patients without cardiac symptoms‏‎ (13:27, 17 June 2019)
  181. Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects‏‎ (13:27, 17 June 2019)
  182. Electrophysiologic assessment of autonomic function in epilepsy‏‎ (13:28, 17 June 2019)
  183. Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system‏‎ (13:28, 17 June 2019)
  184. Entropy measures of heart rate variation in conscious dogs‏‎ (13:28, 17 June 2019)
  185. Epidemiology and classification of epilepsy: Gender comparisons‏‎ (13:28, 17 June 2019)
  186. Epilepsy: A ‘going ape’ model for SUDEP?‏‎ (13:28, 17 June 2019)
  187. Epilepsy and sudden death‏‎ (13:28, 17 June 2019)
  188. Epilepsy and sudden death: A personal view‏‎ (13:28, 17 June 2019)
  189. Epilepsy and sudden death: notes from George Washington's diaries on the illness and death of Martha Parke-Custis (1756-1773)‏‎ (13:28, 17 June 2019)
  190. Epilepsy and sudden death: personal reflections and call for global action‏‎ (13:28, 17 June 2019)
  191. Epilepsy and the long QT syndrome: is there a link? – Commentary on Hindocha et al.‏‎ (13:29, 17 June 2019)
  192. Epilepsy in the elderly: Life expectancy and causes of death‏‎ (13:29, 17 June 2019)
  193. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death‏‎ (13:29, 17 June 2019)
  194. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death‏‎ (13:29, 17 June 2019)
  195. Epileptic cardiac arrhythmia: sinoatrial arrest in two patients: a potential cause of sudden death in epilepsy?‏‎ (13:29, 17 June 2019)
  196. Epileptic seizure-induced hypoxemia in infants with apparent life-threatening events‏‎ (13:29, 17 June 2019)
  197. Epileptic Seizure Prediction Based on Multivariate Statistical Process Control of Heart Rate Variability Features‏‎ (13:29, 17 June 2019)
  198. Epileptic sudden death: Animal models‏‎ (13:29, 17 June 2019)
  199. Equivocal significance of post-ictal generalized EEG suppression as a marker of SUDEP risk‏‎ (13:30, 17 June 2019)
  200. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation‏‎ (13:30, 17 June 2019)
  201. Estimating excess winter mortality in England and Wales‏‎ (13:30, 17 June 2019)
  202. Evaluation of sudden death in epilepsy‏‎ (13:30, 17 June 2019)
  203. Evidence for limbic system activation during CO2-stimulated breathing in man‏‎ (13:30, 17 June 2019)
  204. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice‏‎ (13:30, 17 June 2019)
  205. Evidence supporting role of serotonin in modulation of sudden death induced by seizures in DBA/2 Mice‏‎ (13:30, 17 June 2019)
  206. Excess mortality and sudden unexpected death in epilepsy‏‎ (13:30, 17 June 2019)
  207. Exome-based analysis of cardiac arrhythmia, respiratory control and epilepsy genes in sudden unexpected death in epilepsy‏‎ (13:31, 17 June 2019)
  208. Feature selection methods for accelerometry-based seizure detection in children‏‎ (13:31, 17 June 2019)
  209. Finding the missing link between ictal bradyarrhythmia, ictal asystole, and sudden unexpected death in epilepsy‏‎ (13:31, 17 June 2019)
  210. FMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects‏‎ (13:31, 17 June 2019)
  211. Forensic considerations in sudden unexpected death in epilepsy‏‎ (13:31, 17 June 2019)
  212. From mystery to prevention: Sudden unexpected death in epilepsy, time to move on‏‎ (13:31, 17 June 2019)
  213. From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy‏‎ (13:31, 17 June 2019)
  214. From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy‏‎ (13:31, 17 June 2019)
  215. Functional assessment of heart rate variability: physiological basis and practical applications‏‎ (13:32, 17 June 2019)
  216. Genetic screening for SUDEP? – Commentary on Hindocha et al.‏‎ (13:32, 17 June 2019)
  217. Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy‏‎ (13:32, 17 June 2019)
  218. Hard Choices: Whether and How to Address SUDEP With Epileptic Patients‏‎ (13:32, 17 June 2019)
  219. Heart rate and EKG changes in 102 seizures: Analysis of influencing factors‏‎ (13:32, 17 June 2019)
  220. Heart rate changes and ECG abnormalities during epileptic seizures: Prevalence and definition of an objective clinical sign‏‎ (13:32, 17 June 2019)
  221. Heart rate changes during partial seizures: a study amongst Singaporean patients‏‎ (13:32, 17 June 2019)
  222. Heart rate differences between right and left unilateral electroconvulsive therapy‏‎ (13:32, 17 June 2019)
  223. Heart rate does not decrease after right hemispheric amobarbital injection‏‎ (13:33, 17 June 2019)
  224. Heart rate variability during sleep in children with partial epilepsy‏‎ (13:33, 17 June 2019)
  225. Heart rate variability in children with refractory generalized epilepsy‏‎ (13:33, 17 June 2019)
  226. Heart rate variability in patients with epilepsy‏‎ (13:33, 17 June 2019)
  227. Heart rate variability in patients with frontal lobe epilepsy‏‎ (13:33, 17 June 2019)
  228. Heart rate variability in patients with untreated epilepsy‏‎ (13:33, 17 June 2019)
  229. Heart rate variability: Standards of measurement, physiological interpretation and clinical use‏‎ (13:33, 17 June 2019)
  230. Hemispheric influence on autonomic modulation and baroreflex sensitivity‏‎ (13:33, 17 June 2019)
  231. Hippocampal activity during transient respiratory events in the freely behaving cat‏‎ (13:34, 17 June 2019)
  232. Ictal apnea linked to contralateral spread of temporal lobe seizures: Intracranial EEG recordings in refractory temporal lobe epilepsy‏‎ (13:34, 17 June 2019)
  233. Ictal apnea of epileptic origin‏‎ (13:34, 17 June 2019)
  234. Ictal asystole: A benign condition?‏‎ (13:34, 17 June 2019)
  235. Ictal asystole – Late manifestation of partial epilepsy and importance of cardiac pacemaker‏‎ (13:34, 17 June 2019)
  236. Ictal asystole in temporal lobe epilepsy before and after pacemaker implantation‏‎ (13:34, 17 June 2019)
  237. Ictal asystole with convulsive syncope mimicking secondary generalisation: A depth electrode study‏‎ (13:35, 17 June 2019)
  238. Ictal bradycardia followed by cardiac asystole: A case report‏‎ (13:35, 17 June 2019)
  239. Ictal bradycardia in a patient with a hypothalamic hamartoma: A stereo-EEG study‏‎ (13:35, 17 June 2019)
  240. Ictal bradycardia in partial epileptic seizures: Autonomic investigation in three cases and literature review‏‎ (13:35, 17 June 2019)
  241. Ictal changes in parasympathetic tone: Prediction of postictal oxygen desaturation‏‎ (13:35, 17 June 2019)
  242. Ictal ECG changes in temporal lobe epilepsy‏‎ (13:35, 17 June 2019)
  243. Ictal hypoventilation contributes to cardiac arrhythmia and sudep: Report on two deaths in video-eeg-monitored patients‏‎ (13:35, 17 June 2019)
  244. Ictal hypoventilation contributes to cardiac arrhythmia and SUDEP: report on two deaths in video-EEG-monitored patients‏‎ (13:35, 17 June 2019)
  245. Ictal hypoxemia in localization-related epilepsy: Analysis of incidence, severity and risk factors‏‎ (13:35, 17 June 2019)
  246. Ictal tachycardia during temporal lobe seizures‏‎ (13:36, 17 June 2019)
  247. Ictal tachycardia: Its discriminating potential between temporal and extratemporal seizure foci‏‎ (13:36, 17 June 2019)
  248. Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy‏‎ (13:36, 17 June 2019)
  249. Idiopathic cardiac asystole presenting as an intractable adult onset partial seizure disorder‏‎ (13:36, 17 June 2019)
  250. Impact of periictal interventions on respiratory dysfunction, postictal EEG suppression, and postictal immobility‏‎ (13:36, 17 June 2019)
  251. Impact of periictal nurse interventions on postictal generalized EEG suppression in generalized convulsive seizures‏‎ (13:36, 17 June 2019)
  252. Impaired baroreflex function in temporal lobe epilepsy‏‎ (13:36, 17 June 2019)
  253. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study‏‎ (13:36, 17 June 2019)
  254. Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study‏‎ (13:37, 17 June 2019)
  255. Incidence and significance of periictal apnea in epileptic seizures‏‎ (13:37, 17 June 2019)
  256. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre‏‎ (13:37, 17 June 2019)
  257. Increased pulmonary vascular permeability follows intracranial hypertension in sheep‏‎ (13:37, 17 June 2019)
  258. Increased QT dispersion in epileptic children‏‎ (13:37, 17 June 2019)
  259. Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002‏‎ (13:37, 17 June 2019)
  260. Information on sudden deaths from epilepsy‏‎ (13:37, 17 June 2019)
  261. Inhibition of adenosine metabolism induces changes in post-ictal depression, respiration, and mortality in genetically epilepsy prone rats‏‎ (13:37, 17 June 2019)
  262. Insights from the study of heart rate variability‏‎ (13:38, 17 June 2019)
  263. Interactions between respiration and circulation‏‎ (13:38, 17 June 2019)
  264. Interictal autonomic nervous system function in patients with epilepsy‏‎ (13:38, 17 June 2019)
  265. Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by 123I-metaiodobenzylguanidine-SPECT‏‎ (13:38, 17 June 2019)
  266. Interictal heart rate patterns in partial seizure disorders‏‎ (13:38, 17 June 2019)
  267. Interspike intervals during interictal periods in human temporal lobe epilepsy‏‎ (13:38, 17 June 2019)
  268. Ischemic and anoxic dissolution of the supramedullary control of respiration‏‎ (13:38, 17 June 2019)
  269. Is cold the new hot in sudden unexpected death in epilepsy? Effect of low temperature on heart rate of rats with epilepsy‏‎ (13:38, 17 June 2019)
  270. Is geomagnetic activity a risk factor for sudden unexplained death in epilepsies?‏‎ (13:39, 17 June 2019)
  271. Is sudden unexplained death in adult epileptic patients associated with geomagnetic disturbances at the day of death or the 4 days before?‏‎ (13:39, 17 June 2019)
  272. Is there progress in the autopsy diagnosis of sudden unexpected death in adults?‏‎ (13:39, 17 June 2019)
  273. Is there something special about cardiovascular abnormalities and sudden unexpected death in epilepsy among patients with chronic renal insufficiency in regular hemodialysis program?‏‎ (13:39, 17 June 2019)
  274. Keeping patients with epilepsy safe: a surmountable challenge?‏‎ (13:39, 17 June 2019)
  275. Kindled seizures activate both branches of the autonomic nervous system‏‎ (13:39, 17 June 2019)
  276. Kindled seizures elevate blood pressure and induce cardiac arrhythmias‏‎ (13:39, 17 June 2019)
  277. Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy‏‎ (13:39, 17 June 2019)
  278. Lamotrigine in idiopathic epilepsy – Increased risk of cardiac death‏‎ (13:40, 17 June 2019)
  279. Lamotrigine in idiopathic epilepsy – Increased risk of cardiac death?‏‎ (13:40, 17 June 2019)
  280. Laryngospasm, central and obstructive apnea during seizures: Defining pathophysiology for sudden death in a rat model‏‎ (13:40, 17 June 2019)
  281. Lateralized and widespread brain activation during transient blood pressure elevation revealed by magnetic resonance imaging‏‎ (13:40, 17 June 2019)
  282. Lengthening of corrected QT during epileptic seizures‏‎ (13:40, 17 June 2019)
  283. Levels of integration of respiratory patterns‏‎ (13:40, 17 June 2019)
  284. Life expectancy in epilepsy‏‎ (13:40, 17 June 2019)
  285. Limbic forebrain and midbrain modulation and phase-switching of expiratory neurons‏‎ (13:40, 17 June 2019)
  286. Limbic system modulation of respiratory neurones‏‎ (13:41, 17 June 2019)
  287. Living with epileptic seizures‏‎ (13:41, 17 June 2019)
  288. Long-duration self-sustained epileptiform activity in the hippocampal-parahippocampal slice: A model of status epilepticus‏‎ (13:41, 17 June 2019)
  289. Long-term mortality in childhood-onset epilepsy‏‎ (13:41, 17 June 2019)
  290. Long-term survival after epilepsy surgery compared with matched epilepsy controls and the general population‏‎ (13:41, 17 June 2019)
  291. Many people with epilepsy want to know more: a qualitative study‏‎ (13:41, 17 June 2019)
  292. Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention‏‎ (13:41, 17 June 2019)
  293. Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention‏‎ (13:41, 17 June 2019)
  294. Microglia PACAP and glutamate: Friends or foes in seizure-induced autonomic dysfunction and SUDEP?‏‎ (13:42, 17 June 2019)
  295. Mortality from epilepsy. International patterns and changes over time‏‎ (13:42, 17 June 2019)
  296. Mortality from epilepsy: Results from a prospective population-based study‏‎ (13:42, 17 June 2019)
  297. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: A case-control study‏‎ (13:42, 17 June 2019)
  298. Mortality in adults with newly diagnosed and chronic epilepsy: A retrospective comparative study‏‎ (13:42, 17 June 2019)
  299. Mortality in antiepileptic drug development programs‏‎ (13:42, 17 June 2019)
  300. Mortality in a population-based cohort of epilepsy surgery patients‏‎ (13:42, 17 June 2019)
  301. Mortality in captive baboons with seizures: A new model for SUDEP?‏‎ (13:42, 17 June 2019)
  302. Mortality in children with epilepsy. A clinical prospective study‏‎ (13:42, 17 June 2019)
  303. Mortality in Dravet Syndrome‏‎ (13:43, 17 June 2019)
  304. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort‏‎ (13:43, 17 June 2019)
  305. Mortality in epilepsy in the west of Ireland: A 10-year review‏‎ (13:43, 17 June 2019)
  306. Mortality in patients with epilepsy: A study of patients in long term residential care‏‎ (13:43, 17 June 2019)
  307. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome‏‎ (13:43, 17 June 2019)
  308. N-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study‏‎ (13:43, 17 June 2019)
  309. National General Practice Study of Epilepsy and Epileptic Seizures: Objectives and study methodology of the largest reported prospective cohort study of epilepsy‏‎ (13:43, 17 June 2019)
  310. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome‏‎ (13:43, 17 June 2019)
  311. Neural mechanisms in cardiac arrhythmias associated with epileptogenic activity: the effect of phenobarbital in the cat‏‎ (13:44, 17 June 2019)
  312. Neurocardiac responses to vagoafferent electrostimulation in humans‏‎ (13:44, 17 June 2019)
  313. Neurogenic pulmonary edema in unexpected, unexplained death of epileptic patients‏‎ (13:44, 17 June 2019)
  314. Neuronal synchrony in relation to burst discharge in epileptic human temporal lobes‏‎ (13:44, 17 June 2019)
  315. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy‏‎ (13:44, 17 June 2019)
  316. No apparent effect of surgery for temporal lobe epilepsy on heart rate variability‏‎ (13:44, 17 June 2019)
  317. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study‏‎ (13:44, 17 June 2019)
  318. Non-EEG based ambulatory seizure detection designed for home use: What is available and how will it influence epilepsy care?‏‎ (13:44, 17 June 2019)
  319. Non-EEG seizure detection systems and potential SUDEP prevention: State of the art: Review and update‏‎ (13:45, 17 June 2019)
  320. Non-invasive assessment of cardioregulatory autonomic functions in children with epilepsy‏‎ (13:45, 17 June 2019)
  321. Nonseizure SUDEP: Sudden unexpected death in epilepsy without preceding epileptic seizures‏‎ (13:45, 17 June 2019)
  322. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope‏‎ (13:45, 17 June 2019)
  323. Observations on some cases of permanently slow pulse‏‎ (13:45, 17 June 2019)
  324. Obstructive apnea due to laryngospasm links ictal to postictal events in SUDEP cases and offers practical biomarkers for review of past cases and prevention of new ones‏‎ (13:45, 17 June 2019)
  325. On the modes of death in epilepsy‏‎ (13:45, 17 June 2019)
  326. Outcome of epilepsy surgery correlates with sympathetic modulation and neuroimaging of the heart‏‎ (13:45, 17 June 2019)
  327. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery‏‎ (13:46, 17 June 2019)
  328. Oxygenation prevents sudden death in seizure-prone mice‏‎ (13:46, 17 June 2019)
  329. Oxygen desaturations triggered by partial seizures: Implications for cardiopulmonary instability in epilepsy‏‎ (13:46, 17 June 2019)
  330. Parental and physician beliefs regarding the provision and content of written sudden unexpected death in epilepsy (SUDEP) information‏‎ (13:46, 17 June 2019)
  331. Paroxysmal autonomic dysfunction, epileptogenic activity and sudden death‏‎ (13:46, 17 June 2019)
  332. Partial epilepsy presenting as episodic dyspnea: A specific network involved in limbic seizure propagation‏‎ (13:46, 17 June 2019)
  333. Partial epileptic seizures of different origin variably affect cardiac rhythm‏‎ (13:46, 17 June 2019)
  334. Partial seizures manifesting as apnea only in an adult‏‎ (13:46, 17 June 2019)
  335. Partial seizures presenting as life-threatening apnea‏‎ (13:47, 17 June 2019)
  336. Partial seizures with apnea and bradycardia‏‎ (13:47, 17 June 2019)
  337. Pathogenesis of neurogenic pulmonary oedema‏‎ (13:47, 17 June 2019)
  338. Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case-control study‏‎ (13:47, 17 June 2019)
  339. Patient-centered design criteria for wearable seizure detection devices‏‎ (13:47, 17 June 2019)
  340. Patients with epilepsy who die suddenly do not always have cardiac disease‏‎ (13:47, 17 June 2019)
  341. Patients with epilepsy who die suddenly have cardiac disease‏‎ (13:47, 17 June 2019)
  342. Periodic respiratory pattern occurring in conjunction with eye movements during sleep‏‎ (13:47, 17 June 2019)
  343. Persistence of impaired autoregulation of cerebral blood flow in the postictal period in piglets‏‎ (13:48, 17 June 2019)
  344. Phase-switching of respiration induced by central gray and hippocampal stimulation in the cat‏‎ (13:48, 17 June 2019)
  345. Phenytoin and phenobarbital inhibit human HERG potassium channels‏‎ (13:48, 17 June 2019)
  346. Physiological evidence concerning importance of the amygdaloid nuclear region in the integration of circulatory function and emotion in man‏‎ (13:48, 17 June 2019)
  347. Population-based study of the incidence of sudden unexplained death in epilepsy‏‎ (13:48, 17 June 2019)
  348. Postictal apnea as an important mechanism for SUDEP: A near-SUDEP with continuous EEG-ECG-EMG recording‏‎ (13:48, 17 June 2019)
  349. Postictal breathing pattern distinguishes epileptic from nonepileptic convulsive seizures‏‎ (13:49, 17 June 2019)
  350. Postictal central apnea as a cause of SUDEP: Evidence from near-SUDEP incident‏‎ (13:49, 17 June 2019)
  351. Postictal generalized EEG suppression and respiratory dysfunction following generalized tonic–clonic seizures in sleep and wakefulness‏‎ (13:49, 17 June 2019)
  352. Postictal Generalized EEG Suppression and SUDEP: A Review‏‎ (13:49, 17 June 2019)
  353. Postictal generalized EEG suppression: an inconsistent finding in people with multiple seizures‏‎ (13:49, 17 June 2019)
  354. Postictal generalized EEG suppression is linked to seizure-associated respiratory dysfunction but not postictal apnea‏‎ (13:49, 17 June 2019)
  355. Postictal generalized electroencephalographic suppression is associated with generalized seizures‏‎ (13:49, 17 June 2019)
  356. Postictal heart rate oscillations in partial epilepsy‏‎ (13:49, 17 June 2019)
  357. Postictal immobility and generalized EEG suppression are associated with the severity of respiratory dysfunction‏‎ (13:50, 17 June 2019)
  358. Postictal increase in T-wave alternans after generalized tonic–clonic seizures‏‎ (13:50, 17 June 2019)
  359. Postmortem changes in blood concentrations of phenytoin and carbamazepine: An experimental study‏‎ (13:50, 17 June 2019)
  360. Post-mortem findings of cardiac lesions in epileptics: a preliminary report‏‎ (13:50, 17 June 2019)
  361. Post-mortem review and genetic analysis of sudden unexpected death in epilepsy cases‏‎ (13:50, 17 June 2019)
  362. Power spectrum analysis of heart rate variability in children with epilepsy‏‎ (13:50, 17 June 2019)
  363. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors‏‎ (13:50, 17 June 2019)
  364. Premature deaths in persons with seizure disorders – Subtherapeutic levels of anticonvulsant drugs in postmortem blood specimens‏‎ (13:50, 17 June 2019)
  365. Preoperative heart rate variability in relation to surgery outcome in refractory epilepsy‏‎ (13:51, 17 June 2019)
  366. Present status of the relationship of brain structures to the circulation and emotional expression in man‏‎ (13:51, 17 June 2019)
  367. Prevalence of cardiac conduction disturbances during carbamazepine treatment: Preliminary data‏‎ (13:51, 17 June 2019)
  368. Preventing tomorrow’s sudden cardiac death in epilepsy today: What should physicians know about this?‏‎ (13:51, 17 June 2019)
  369. Prevention of sudden unexpected death in epilepsy:A realistic goal?‏‎ (13:51, 17 June 2019)
  370. Profiles of instant heart rate during partial seizures‏‎ (13:51, 17 June 2019)
  371. Projections to areas of the nucleus tractus solitarii related to circulatory and respiratory responses in cats‏‎ (13:51, 17 June 2019)
  372. Prolactin levels in sudden unexpected death in epilepsy‏‎ (13:51, 17 June 2019)
  373. Prolongation of the QT interval and the sudden infant death syndrome‏‎ (13:51, 17 June 2019)
  374. Psychoactive agents, seizure production, and sudden death in epilepsy‏‎ (13:52, 17 June 2019)
  375. Pulmonary afferent and central influences on respiratory phase-switching in the cat‏‎ (13:52, 17 June 2019)
  376. QT dispersion‏‎ (13:52, 17 June 2019)
  377. Quantitative analysis of surface electromyography: Biomarkers for convulsive seizures‏‎ (13:52, 17 June 2019)
  378. Recognizing and preventing epilepsy-related mortality: A call for action‏‎ (13:52, 17 June 2019)
  379. Recurring discharge patterns in multiple spike trains‏‎ (13:52, 17 June 2019)
  380. Reducing mortality: An important aim of epilepsy management‏‎ (13:52, 17 June 2019)
  381. Regional brain activation in humans during respiratory and blood pressure challenges‏‎ (13:52, 17 June 2019)
  382. Relation between ictal asystole and cardiac sympathetic dysfunction shown by MIBG-SPECT‏‎ (13:53, 17 June 2019)
  383. Relationships between hippocampal activity and breathing patterns‏‎ (13:53, 17 June 2019)
  384. Report of the American Epilepsy Society and the Epilepsy Foundation joint task force on sudden unexplained death in epilepsy‏‎ (13:53, 17 June 2019)
  385. Respiratory arrest from seizure discharges in the limbic system‏‎ (13:53, 17 June 2019)
  386. Respiratory changes with seizures in localization-related epilepsy: Analysis of periictal hypercapnia and airflow patterns‏‎ (13:53, 17 June 2019)
  387. Respiratory modulation of neuronal discharge in the central nucleus of the amygdala during sleep and waking states‏‎ (13:53, 17 June 2019)
  388. Respiratory Pathophysiology With Seizures and Implications for Sudden Unexpected Death in Epilepsy‏‎ (13:53, 17 June 2019)
  389. Respiratory responses to stimulation of temporal pole, insula, and hippocampal and limbic gyri in man‏‎ (13:53, 17 June 2019)
  390. Review of autonomic dysfunction, cardiac arrhythmias, and epileptogenic activity‏‎ (13:54, 17 June 2019)
  391. Review of the legal obligations of the doctor to discuss Sudden Unexplained Death in Epilepsy (SUDEP) – A cohort controlled comparative cross-matched study in an outpatient epilepsy clinic‏‎ (13:54, 17 June 2019)
  392. Right ventromedial prefrontal lesions result in paradoxical cardiovascular activation with emotional stimuli‏‎ (13:54, 17 June 2019)
  393. Risk Assessment for Sudden Deathin Epilepsy: The SUDEP-7 Inventory‏‎ (13:54, 17 June 2019)
  394. Risk factors for sudden unexpected death in epilepsy: A case-control study‏‎ (13:54, 17 June 2019)
  395. Risk factors for sudden unexpected death in epilepsy: A controlled prospective study based on coroners cases‏‎ (13:54, 17 June 2019)
  396. Risk factors in sudden death in epilepsy (SUDEP): The quest for mechanisms‏‎ (13:54, 17 June 2019)
  397. Risk factors of postictal generalized EEG suppression in generalized convulsive seizures‏‎ (13:54, 17 June 2019)
  398. Risk of Sudden unexpected death in patients given adjunctive epilepsy treatment for refractory seizures: a meta-analysis of placebo-controlled trials‏‎ (13:55, 17 June 2019)
  399. Seasonality as a risk factor for sudden unexpected death in epilepsy: A study in a large cohort‏‎ (13:55, 17 June 2019)
  400. Seizure control and mortality in epilepsy‏‎ (13:55, 17 June 2019)
  401. Seizure related autonomic changes in children‏‎ (13:55, 17 June 2019)
  402. Seizure-related injuries are underreported in pharmacoresistant localization-related epilepsy‏‎ (13:55, 17 June 2019)
  403. Seizures and brain regulatory systems: consciousness, sleep, and autonomic systems‏‎ (13:55, 17 June 2019)
  404. Selective paralysis of voluntary but not limbically influenced automatic respiration‏‎ (13:55, 17 June 2019)
  405. Sensory, motor and autonomic effects of mesial temporal stimulation in man‏‎ (13:55, 17 June 2019)
  406. Severe myoclonic epilepsy in infancy: Dravet syndrome‏‎ (13:56, 17 June 2019)
  407. Severe postictal laryngospasm as a potential mechanism for sudden unexpected death in epilepsy: A near-miss in an EMU‏‎ (13:56, 17 June 2019)
  408. Severe pulmonary congestion in a near miss at the first seizure: Further evidence for respiratory dysfunction in sudden unexpected death in epilepsy‏‎ (13:56, 17 June 2019)
  409. Short QTc in epilepsy patients without cardiac symptoms‏‎ (13:56, 17 June 2019)
  410. Should all patients be told about sudden unexpected death in epilepsy (SUDEP)? Pros and Cons‏‎ (13:56, 17 June 2019)
  411. Should patients or their families be told of the risk of Sudden Unexplained Death in Epilepsy?‏‎ (13:56, 17 June 2019)
  412. Sino-auricular heart block as an epileptic manifestation: A case report‏‎ (13:56, 17 June 2019)
  413. Sinus arrest in epilepsy‏‎ (13:56, 17 June 2019)
  414. Sinus node recovery time assessment revisited: Role of pharmacologic blockade of the autonomic nervous system‏‎ (13:57, 17 June 2019)
  415. Sleep states attenuate the pressor response to central amygdala stimulation‏‎ (13:57, 17 June 2019)
  416. Some autonomic concomitants of ictal automatism; A study of temporal lobe attack‏‎ (13:57, 17 June 2019)
  417. Some autonomic concomitants of ictal automatism; A study of temporal lobe attacks‏‎ (13:57, 17 June 2019)
  418. Speculations on neurogenic pulmonary edema (NPE)‏‎ (13:57, 17 June 2019)
  419. Spreading depolarization in the brainstem mediates sudden cardiorespiratory arrest in mouse SUDEP models‏‎ (13:57, 17 June 2019)
  420. SSRI are associated with reduced severity of ictal hypoxemia in medically refractory partial epilepsy‏‎ (13:57, 17 June 2019)
  421. State-dependent alteration of respiratory cycle timing by stimulation of the central nucleus of the amygdala‏‎ (13:57, 17 June 2019)
  422. Stertorous breathing is a reliably identified sign that helps in the differentiation of epileptic from psychogenic non-epileptic convulsions: An audit‏‎ (13:58, 17 June 2019)
  423. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group‏‎ (13:58, 17 June 2019)
  424. Stress and sudden death‏‎ (13:58, 17 June 2019)
  425. Sudden and unexpected death in epilepsy (SUDEP): evidence of acute neuronal injury using HSP-70 and c-Jun immunohistochemistry‏‎ (13:58, 17 June 2019)
  426. Sudden and unexpected natural death in childhood and adolescence‏‎ (13:58, 17 June 2019)
  427. Sudden cardiac arrest in people with epilepsy in the community: Circumstances and risk factors‏‎ (13:58, 17 June 2019)
  428. Sudden death and epilepsy‏‎ (13:58, 17 June 2019)
  429. Sudden death, febrile seizures, and hippocampal maldevelopment in toddlers: A new entity‏‎ (13:58, 17 June 2019)
  430. Sudden death from hypoventilation during epileptic seizures‏‎ (13:58, 17 June 2019)
  431. Sudden death in epilepsy. A comprehensive review of the literature and proposed mechanisms‏‎ (13:59, 17 June 2019)
  432. Sudden death in epilepsy: An avoidable outcome?‏‎ (13:59, 17 June 2019)
  433. Sudden death in epilepsy: An experimental animal model‏‎ (13:59, 17 June 2019)
  434. Sudden death in epilepsy: A study of incidence in a young cohort with epilepsy and learning difficulty‏‎ (13:59, 17 June 2019)
  435. Sudden death in epilepsy: A wake-up call for management‏‎ (13:59, 17 June 2019)
  436. Sudden death in epilepsy recorded in ambulatory EEG‏‎ (13:59, 17 June 2019)
  437. Sudden death in epileptic rats exposed to nocturnal magnetic fields that simulate the shape and the intensity of sudden changes in geomagnetic activity: An experiment in response to Schnabel, Beblo and May‏‎ (13:59, 17 June 2019)
  438. Sudden death in toddlers associated with developmental abnormalities of the hippocampus: a report of five cases‏‎ (13:59, 17 June 2019)
  439. Sudden epilepsy deaths and the forensic pathologist‏‎ (14:00, 17 June 2019)
  440. Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates‏‎ (14:00, 17 June 2019)
  441. Sudden unexpected death associated with seizures: Analysis of 66 cases‏‎ (14:00, 17 June 2019)
  442. Sudden unexpected death in a mouse model of Dravet syndrome‏‎ (14:00, 17 June 2019)
  443. Sudden unexpected death in epilepsy: A local audit‏‎ (14:00, 17 June 2019)
  444. Sudden unexpected death in epilepsy: a retrospective study‏‎ (14:00, 17 June 2019)
  445. Sudden unexpected death in epilepsy: A retrospective study‏‎ (14:00, 17 June 2019)
  446. Sudden unexpected death in epilepsy: a review of incidence and risk factors‏‎ (14:00, 17 June 2019)
  447. Sudden unexpected death in epilepsy: A search for risk factors‏‎ (14:01, 17 June 2019)
  448. Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death‏‎ (14:01, 17 June 2019)
  449. Sudden unexpected death in epilepsy: a series of witnessed deaths‏‎ (14:01, 17 June 2019)
  450. Sudden unexpected death in epilepsy: assessing the public health burden‏‎ (14:01, 17 June 2019)
  451. Sudden unexpected death in epilepsy: Current knowledge and future directions‏‎ (14:01, 17 June 2019)
  452. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention‏‎ (14:01, 17 June 2019)
  453. Sudden unexpected death in epilepsy: Evidence-based analysis of incidence and risk factors‏‎ (14:01, 17 June 2019)
  454. Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention‏‎ (14:01, 17 June 2019)
  455. Sudden unexpected death in epilepsy: Identifying risk and preventing mortality‏‎ (14:02, 17 June 2019)
  456. Sudden unexpected death in epilepsy: Impact, mechanisms, and prevention‏‎ (14:02, 17 June 2019)
  457. Sudden unexpected death in epilepsy: Impact on clinical practice‏‎ (14:02, 17 June 2019)
  458. Sudden unexpected death in epilepsy in adults with mental retardation‏‎ (14:02, 17 June 2019)
  459. Sudden unexpected death in epilepsy in children and adolescents‏‎ (14:02, 17 June 2019)
  460. Sudden unexpected death in epilepsy in Victoria‏‎ (14:02, 17 June 2019)
  461. Sudden unexpected death in epilepsy: Is carbamazepine implicated?‏‎ (14:02, 17 June 2019)
  462. Sudden unexpected death in epilepsy: is death by seizures a cardiac disease?‏‎ (14:02, 17 June 2019)
  463. Sudden unexpected death in epilepsy (Johnston, Smith)‏‎ (14:02, 17 June 2019)
  464. Sudden unexpected death in epilepsy: Knowledge and experience among US and Canadian neurologists‏‎ (14:03, 17 June 2019)
  465. Sudden unexpected death in epilepsy (Lhatoo, Langan, Sander)‏‎ (14:03, 17 June 2019)
  466. Sudden unexpected death in epilepsy (Lhatoo, Sander)‏‎ (14:03, 17 June 2019)
  467. Sudden unexpected death in epilepsy patients: Risk factors. A systematic review‏‎ (14:03, 17 June 2019)
  468. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk‏‎ (14:03, 17 June 2019)
  469. Sudden unexpected death in epilepsy: Risk factors and potential pathomechanisms‏‎ (14:03, 17 June 2019)
  470. Sudden unexpected death in epilepsy. Risk factors, possible 225 mechanisms and prevention: A reappraisal‏‎ (14:03, 17 June 2019)
  471. Sudden unexpected death in epilepsy (SUDEP): A clinical perspective and a search for risk factors‏‎ (14:03, 17 June 2019)
  472. Sudden unexpected death in epilepsy (SUDEP): Don’t ask, don’t tell?‏‎ (14:04, 17 June 2019)
  473. Sudden unexpected death in epilepsy (SUDEP): Risk factors and case control studies‏‎ (14:04, 17 June 2019)
  474. Sudden unexpected death in epilepsy (SUDEP): Update and reflections‏‎ (14:04, 17 June 2019)
  475. Sudden unexpected death in epilepsy: Terminology and definitions‏‎ (14:04, 17 June 2019)
  476. Sudden unexpected death in epileptics following sudden, intense, increases in geomagnetic activity: Prevalence of effect and potential mechanisms‏‎ (14:04, 17 June 2019)
  477. Sudden unexpected death in people with epilepsy: A pediatric perspective‏‎ (14:04, 17 June 2019)
  478. Sudden unexpected death in young adults including four cases of SADS: A 10-year review from the west of Ireland‏‎ (14:04, 17 June 2019)
  479. Sudden unexpected death of epileptic patient due to cardiac arrhythmia after seizure‏‎ (14:04, 17 June 2019)
  480. Sudden unexpected deaths in epilepsy – Where are we now?‏‎ (14:05, 17 June 2019)
  481. Sudden unexpected, unexplained death in epilepsy autopsied patients‏‎ (14:05, 17 June 2019)
  482. Sudden unexplained death among subjects with refractory epilepsy‏‎ (14:05, 17 June 2019)
  483. Sudden unexplained death and injury in epilepsy‏‎ (14:05, 17 June 2019)
  484. Sudden unexplained death explained?‏‎ (14:05, 17 June 2019)
  485. Sudden unexplained death in children with epilepsy‏‎ (14:05, 17 June 2019)
  486. Sudden unexplained death in children with epilepsy: A cohort study with an eighteen-year follow-up‏‎ (14:05, 17 June 2019)
  487. Sudden unexplained death in epilepsy: An intracranially monitored case‏‎ (14:05, 17 June 2019)
  488. Sudden unexplained death in epilepsy: observations from a large clinical development program‏‎ (14:05, 17 June 2019)
  489. Sudden unexplained death in epilepsy: The role of the heart‏‎ (14:06, 17 June 2019)
  490. Sudden unexplained death in young persons with primary epilepsy‏‎ (14:06, 17 June 2019)
  491. Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep‏‎ (14:06, 17 June 2019)
  492. SUDEP – Whether to tell and when‏‎ (14:06, 17 June 2019)
  493. SUDEP in the Netherlands: A retrospective study in a tertiary referral center‏‎ (14:06, 17 June 2019)
  494. SUDEP: Overview of definitions and review of incidence data‏‎ (14:06, 17 June 2019)
  495. SUDEP: The death of nihilism‏‎ (14:06, 17 June 2019)
  496. SUDEP: Time for prevention—evidence and clinical translation. Proceedings from the Epilepsy Research UK 2014 Expert Workshop‏‎ (14:06, 17 June 2019)
  497. Suppressed circadian heart rate dynamics in temporal lobe epilepsy‏‎ (14:07, 17 June 2019)
  498. Suprapontine influences on respiratory patterning during sleep-waking states‏‎ (14:07, 17 June 2019)
  499. Switching of the respiratory phases and evoked phrenic responses produced by rostral pontine electrical stimulation‏‎ (14:07, 17 June 2019)
  500. Symposium on the neurophysiology of Sudden Unexpected Death in Epilepsy‏‎ (14:07, 17 June 2019)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://sudepwiki.pathology.jhmi.edu/index.php/Special:AncientPages"